Risk of exacerbations, hospitalisation, and mortality in adults with physician-diagnosed chronic obstructive pulmonary disease with normal spirometry and adults with preserved ratio impaired spirometry in Sweden: retrospective analysis of data from a
This study is performed with support from The Swedish Heart-Lung Foundation (20200150) and the Swedish government and country council ALF grant (ALFGBG-824371).
Authors
- Lowie E.G.W. Vanfleteren (ORCID: https://orcid.org/0000-0002-4387-4096)
- Fredrik Nyberg (ORCID: https://orcid.org/0000-0003-0892-5668)
- Oskar Wallström (ORCID: https://orcid.org/0000-0003-0532-5034)
- Anne Lindberg (ORCID: https://orcid.org/0000-0002-3292-7471)
- Helena Bäckman (ORCID: https://orcid.org/0000-0002-0553-8067)
- Caroline Stridsman (ORCID: https://orcid.org/0000-0001-6622-3838)
- Sigrid Anna Aalberg Vikjord (ORCID: https://orcid.org/0000-0002-7202-4517)
Institutions
- Levanger Hospital (NO)
- Sahlgrenska University Hospital (SE)
- University of Gothenburg (SE)
- Umeå University (SE)
Publication Details
- Journal
- The Lancet Regional Health - Europe
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1016/j.lanepe.2025.101322
- Citations
- 3
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- AstraZeneca
- Sanofi
- ResMed
- Hjärt-Lungfonden
- Grifols